Jayson Bedford
Stock Analyst at Raymond James
(3.74)
# 739
Out of 5,237 analysts
323
Total ratings
52.96%
Success rate
6.69%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Downgrades: Outperform | $97 → $88 | $53.37 | +64.89% | 27 | Mar 30, 2026 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $178.50 | - | 8 | Mar 27, 2026 | |
| TFX Teleflex | Upgrades: Outperform | $128 | $129.72 | -1.33% | 13 | Mar 27, 2026 | |
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $40.79 | -33.81% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $420.06 | +43.55% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $20.06 | -5.28% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $82.56 | +76.84% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $221.43 | -5.61% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $79.58 | +42.00% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $124.68 | +44.37% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $102 | $60.31 | +69.13% | 28 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $99 → $102 | $59.33 | +71.92% | 31 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $154.17 | +133.51% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $143.15 | +88.61% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.84 | -7.75% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.73 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.77 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $77.17 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.53 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $74.54 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $5.77 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.89 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.97 | - | 3 | Jan 2, 2018 |
Boston Scientific
Mar 30, 2026
Downgrades: Outperform
Price Target: $97 → $88
Current: $53.37
Upside: +64.89%
Masimo
Mar 27, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $178.50
Upside: -
Teleflex
Mar 27, 2026
Upgrades: Outperform
Price Target: $128
Current: $129.72
Upside: -1.33%
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $40.79
Upside: -33.81%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $420.06
Upside: +43.55%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $20.06
Upside: -5.28%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $82.56
Upside: +76.84%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $221.43
Upside: -5.61%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $79.58
Upside: +42.00%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $124.68
Upside: +44.37%
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $60.31
Upside: +69.13%
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $59.33
Upside: +71.92%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $154.17
Upside: +133.51%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $143.15
Upside: +88.61%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.84
Upside: -7.75%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.73
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $14.77
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $77.17
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $17.53
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $74.54
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $5.77
Upside: -
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.89
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.97
Upside: -